Psy5 - Patients With Relapsing Anca-Associated Vasculitis (Aav) Experience Unmet Needs and Utilise Significant Healthcare Resources

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2582
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Psy78 - The Economic and Healthcare Burden of Anca-Associated Vasculitis (Aav) in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy4 - Response to Induction Therapy, Treatment Adverse Events and Healthcare Resource Use in Incident Anca-Associated Vasculitis (Aav) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Anca-Associated Vasculitis

The Journal of scientific articles Health and Education millennium
2018English

Rheumatoid Arthritis With ANCA Associated Vasculitis

Internet Journal of Rheumatology and Clinical Immunology
2018English

Genetics of ANCA-Associated Vasculitis

Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
2019English

Animal Models of ANCA Associated Vasculitis

Frontiers in Immunology
AllergyImmunology
2020English

Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients With Renal ANCA-associated Vasculitis: Association With Risk to Relapse

Journal of Rheumatology
RheumatologyAllergyImmunology
2015English

Should Rituximab Be Used to Prevent Relapse in Patients With ANCA-Associated Vasculitis?

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

Proteinase 3-Anca Vasculitis Versus Myeloperoxidase-Anca Vasculitis

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy